Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
B4GALT3 | UDP-Gal |
|
Benzyl-[alpha] | |
B4GALT4 | UDP-Gal |
|
[alpha]-1-Benzyl | |
B4GALNT4 | UDP-GalNAc |
|
[alpha]-Bz | |
B3GALNT2 | UDP-GalNAc |
|
[alpha]-Bz | |
B3GALNT2 | UDP-GalNAc |
|
[beta]-pNP |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
Q9UKP4 | A disintegrin and metalloproteinase with thrombospondin motifs 7 | ||
Q9UKU9 | Angiopoietin-related protein 2 | ||
Q9ULB5 | Cadherin-7 | ||
Q9ULC8 | Palmitoyltransferase ZDHHC8 | ||
Q9ULF5 | Zinc transporter ZIP10 | ||
Q9ULI3 | Protein HEG homolog 1 | ||
Q9UMD9 | Collagen alpha-1(XVII) chain | ||
Q9UMX5 | Neudesin | ||
Q9UNA0 | A disintegrin and metalloproteinase with thrombospondin motifs 5 | ||
Q9UNE0 | Tumor necrosis factor receptor superfamily member EDAR |
Pathway Name | Organism |
---|---|
E.coli O101 | Escherichia coli |
E.coli O103 | Escherichia coli |
E.coli O107 | Escherichia coli |
E.coli O112ab | Escherichia coli |
E.coli O112ac | Escherichia coli |
E.coli O116 | Escherichia coli |
E.coli O117 | Escherichia coli |
E.coli O125ab | Escherichia coli |
E.coli O127 | Escherichia coli |
E.coli O128ab-H27 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
38522000 | Model‐based meta‐analysis to quantify the effects of short interfering <scp>RNA</scp> therapeutics on hepatitis B surface antigen turnover in hepatitis B‐infected mice | Sandra L | 2024 Mar 24 |
|
38204163 | Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases | Li Q | 2024 Mar 06 |
|
38416819 | An unusual dual sugar-binding lectin domain controls the substrate specificity of a mucin-type O-glycosyltransferase | Collette AM | 2024 Mar |
|
38860868 | Incorporation of Intracellular NanoSIMS Tracers to Oligonucleotide Conjugates via Strain Promoted Sydnone–Alkyne Cycloaddition | Lincy-Bianchi L | 2024 Jun 11 |
|
38044204 | A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort | Lee M | 2024 Jun |
|
38993155 | A GalNAc-modified CaCO3 nano-immunomodulator for targeted and responsive immunotherapy against orthotopic liver cancer | Li Y | 2024 Jul 30 |
|
38795858 | Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes | Kundu S | 2024 Jul |
|
38172637 | Host genetic regulation of human gut microbial structural variation | Zhernakova DV | 2024 Jan 03 |
|
38409587 | RNA interference in the era of nucleic acid therapeutics | Jadhav V | 2024 Feb 26 |
|
38535445 | Cloning and Characterization of a Novel N-Acetyl-D-galactosamine-4-O-sulfate Sulfatase, SulA1, from a Marine Arthrobacter Strain | Christensen MD | 2024 Feb 23 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025